Loading...
Loading...
FTRE| Name | Value |
|---|---|
| Revenues | 701.3M |
| Cost of Revenue | 598.2M |
| Gross Profit | 103.1M |
| Operating Expense | 106.8M |
| Operating I/L | -15.9M |
| Other Income/Expense | -12.8M |
| Interest Income | 0.0M |
| Pretax | -28.7M |
| Income Tax Expense | -12.8M |
| Net Income/Loss | -15.9M |
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry, offering phase I-IV clinical trial management, clinical pharmacology, technology-enabled trial solutions, and post-approval services. The company generates revenue by providing these services to pharmaceutical, biotechnology, and medical device organizations.
